Personal tools

Coexpression cluster:C109

From FANTOM5_SSTAR

Revision as of 16:32, 18 May 2012 by Autoedit (talk | contribs) (Created page with "{{Coexpression_clusters |full_id=C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |id=C109 }}")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Full id: C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma



Phase1 CAGE Peaks

Hg19::chr10:129924611..129924662,-p1@MKI67
Hg19::chr10:129924668..129924722,-p2@MKI67
Hg19::chr10:13203543..13203587,+p1@MCM10
Hg19::chr10:14920843..14920886,+p1@SUV39H2
Hg19::chr10:27444268..27444301,+p1@MASTL
Hg19::chr10:5454505..5454540,+p3@NET1
Hg19::chr10:58120996..58121039,-p1@ZWINT
Hg19::chr10:62538228..62538244,+p1@CDK1
Hg19::chr10:62538248..62538260,+p2@CDK1
Hg19::chr10:70231639..70231735,-p1@DNA2
Hg19::chr10:91461337..91461380,+p1@KIF20B
Hg19::chr10:91461386..91461403,+p2@KIF20B
Hg19::chr10:94352819..94352838,+p3@KIF11
Hg19::chr10:94352840..94352868,+p2@KIF11
Hg19::chr10:94352870..94352930,+p1@KIF11
Hg19::chr11:125495862..125495882,+p1@CHEK1
Hg19::chr11:134093827..134093884,-p1@NCAPD3
Hg19::chr11:28129656..28129735,-p1@KIF18A
Hg19::chr11:58912240..58912355,+p1@FAM111A
Hg19::chr11:82612763..82612808,+p1@C11orf82
Hg19::chr12:102513950..102513996,+p1@C12orf48
Hg19::chr12:102513998..102514017,+p2@C12orf48
Hg19::chr12:102514019..102514035,+p3@C12orf48
Hg19::chr12:118454500..118454585,+p1@RFC5
Hg19::chr12:120315104..120315145,-p1@CIT
Hg19::chr12:123011776..123011814,+p1@KNTC1
Hg19::chr12:123011821..123011835,+p2@KNTC1
Hg19::chr12:4647995..4648087,+p1@RAD51AP1
Hg19::chr12:50419177..50419285,-p1@RACGAP1
Hg19::chr12:510795..510835,+p1@CCDC77
Hg19::chr12:57146095..57146149,-p1@PRIM1
Hg19::chr12:98909351..98909454,+p1@TMPO
Hg19::chr13:21750622..21750646,-p2@SKA3
Hg19::chr13:21750659..21750735,-p1@SKA3
Hg19::chr13:34392259..34392321,+p1@RFC3
Hg19::chr13:34392324..34392339,+p4@RFC3
Hg19::chr13:53029568..53029650,+p1@CKAP2
Hg19::chr13:73302047..73302073,+p1@BORA
Hg19::chr14:50154924..50154935,-p1@POLE2
Hg19::chr14:55493763..55493824,-p1@WDHD1
Hg19::chr14:55658252..55658321,-p1@DLGAP5
Hg19::chr14:55658323..55658334,-p2@DLGAP5
Hg19::chr14:97263676..97263764,+p1@VRK1
Hg19::chr15:30918317..30918350,+p1@ARHGAP11B
Hg19::chr15:32907702..32907729,+p1@ARHGAP11A
Hg19::chr15:40453204..40453304,+p1@BUB1B
Hg19::chr15:40453314..40453331,+p2@BUB1B
Hg19::chr15:40675132..40675210,+p1@C15orf23
Hg19::chr15:40886439..40886493,+p1@CASC5
Hg19::chr15:40987349..40987397,+p1@RAD51
Hg19::chr15:40987401..40987416,+p2@RAD51
Hg19::chr15:41624754..41624796,-p1@OIP5
Hg19::chr15:41625060..41625088,+p1@NUSAP1
Hg19::chr15:44119159..44119226,+p1@WDR76
Hg19::chr15:49103196..49103232,-p2@CEP152
Hg19::chr15:49103235..49103301,-p1@CEP152
Hg19::chr15:59397298..59397353,+p1@CCNB2
Hg19::chr15:59397366..59397381,+p2@CCNB2
Hg19::chr15:64673665..64673676,-p2@KIAA0101
Hg19::chr15:66649010..66649067,-p1@TIPIN
Hg19::chr15:89787185..89787263,+p1@FANCI
Hg19::chr15:90118685..90118717,+p2@C15orf42
Hg19::chr15:90118723..90118753,+p1@C15orf42
Hg19::chr15:91260552..91260644,+p1@BLM
Hg19::chr16:46723552..46723612,+p1@ORC6
Hg19::chr16:74700747..74700804,-p1@RFWD3
Hg19::chr16:81040794..81040865,+p1@CENPN
Hg19::chr17:26926005..26926070,-p1@SPAG5
Hg19::chr17:29158962..29159046,+p1@ATAD5
Hg19::chr17:38444115..38444194,+p1@CDC6
Hg19::chr17:38574125..38574168,-p1@TOP2A
Hg19::chr17:38574169..38574180,-p2@TOP2A
Hg19::chr17:41277372..41277418,-p1@BRCA1
Hg19::chr17:48450575..48450618,+p1@EME1
Hg19::chr17:56084578..56084645,-p1@SRSF1
Hg19::chr18:20513782..20513859,+p1@RBBP8
Hg19::chr18:2571528..2571568,+p1@NDC80
Hg19::chr18:2571572..2571606,+p2@NDC80
Hg19::chr1:100598448..100598532,-p1@SASS6
Hg19::chr1:10490477..10490553,+p2@APITD1-CORT
p2@APITD1
Hg19::chr1:163291719..163291730,+p3@NUF2
Hg19::chr1:163291732..163291812,+p1@NUF2
Hg19::chr1:163291814..163291855,+p2@NUF2
Hg19::chr1:169764163..169764240,+p1@C1orf112
Hg19::chr1:173793515..173793551,-p2@CENPL
Hg19::chr1:197115750..197115807,-p1@ASPM
Hg19::chr1:197115818..197115829,-p3@ASPM
Hg19::chr1:200589831..200589855,-p2@KIF14
Hg19::chr1:200589859..200589887,-p1@KIF14
Hg19::chr1:211848955..211848981,-p1@NEK2
Hg19::chr1:212209055..212209147,+p1@DTL
Hg19::chr1:214776516..214776565,+p1@CENPF
Hg19::chr1:214776570..214776593,+p2@CENPF
Hg19::chr1:214776602..214776615,+p3@CENPF
Hg19::chr1:226496833..226496884,-p1@LIN9
Hg19::chr1:242011485..242011542,+p1@EXO1
Hg19::chr1:36235532..36235543,-p3@CLSPN
Hg19::chr1:36235546..36235557,-p2@CLSPN
Hg19::chr1:36235559..36235600,-p1@CLSPN
Hg19::chr1:45205478..45205492,+p4@KIF2C
Hg19::chr1:45205498..45205554,+p1@KIF2C
Hg19::chr1:46713405..46713452,+p1@RAD54L
Hg19::chr1:47779762..47779827,-p1@STIL
p1@TAL1
Hg19::chr1:52870063..52870102,-p1@ORC1
Hg19::chr1:52870104..52870134,-p2@ORC1
Hg19::chr1:63988846..63988908,-p1@ITGB3BP
Hg19::chr1:68962719..68962736,-p2@DEPDC1
Hg19::chr1:91966384..91966454,+p1@CDC7
Hg19::chr20:30327063..30327138,+p1@TPX2
Hg19::chr20:37555048..37555067,+p1@FAM83D
Hg19::chr20:54967243..54967278,-p1@AURKA
Hg19::chr2:109403193..109403270,+p1@CCDC138
Hg19::chr2:111435630..111435648,-p1@BUB1
Hg19::chr2:113522177..113522228,-p1@CKAP2L
Hg19::chr2:113522248..113522259,-p2@CKAP2L
Hg19::chr2:136633940..136634022,-p1@MCM6
Hg19::chr2:136634026..136634039,-p2@MCM6
Hg19::chr2:169746878..169746970,-p1@SPC25
Hg19::chr2:174219559..174219621,+p1@CDCA7
Hg19::chr2:17935383..17935439,+p1@GEN1
Hg19::chr2:201390843..201390936,+p1@SGOL2
Hg19::chr2:97001482..97001488,+p2@NCAPH
Hg19::chr2:97001491..97001550,+p1@NCAPH
Hg19::chr3:108308241..108308316,-p1@KIAA1524
Hg19::chr3:160117418..160117463,+p1@SMC4
Hg19::chr3:172468505..172468582,+p1@ECT2
Hg19::chr3:20227671..20227711,-p1@SGOL1
Hg19::chr3:20227720..20227744,-p2@SGOL1
Hg19::chr3:44803254..44803305,+p1@KIF15
Hg19::chr4:104119488..104119512,-p1@CENPE
Hg19::chr4:104119528..104119570,-p2@CENPE
Hg19::chr4:113558014..113558073,-p1@C4orf21
Hg19::chr4:120987899..120987928,-p2@MAD2L1
Hg19::chr4:120987933..120988022,-p1@MAD2L1
Hg19::chr4:122744998..122745093,-p1@CCNA2
Hg19::chr4:128802038..128802095,+p1@PLK4
Hg19::chr4:154265784..154265819,+p2@MND1
Hg19::chr4:154265825..154265875,+p1@MND1
Hg19::chr4:159592996..159593059,-p1@C4orf46
Hg19::chr4:174255536..174255547,-p2@HMGB2
Hg19::chr4:17812568..17812648,+p1@NCAPG
Hg19::chr4:178230985..178230997,+p3@NEIL3
Hg19::chr4:185655212..185655260,-p1@MLF1IP
Hg19::chr4:185655278..185655291,-p2@MLF1IP
Hg19::chr5:137514782..137514827,+p1@KIF20A
Hg19::chr5:137667459..137667524,-p1@CDC25C
Hg19::chr5:162887629..162887681,+p1@HMMR
Hg19::chr5:59995921..59996000,-p1@DEPDC1B
Hg19::chr5:64858944..64859002,-p1@CENPK
Hg19::chr5:68462944..68463008,+p1@CCNB1
Hg19::chr5:68463044..68463055,+p2@CCNB1
Hg19::chr5:892954..893050,+p1@TRIP13
Hg19::chr6:136571400..136571457,-p1@FAM54A
Hg19::chr6:153304148..153304160,-p3@FBXO5
Hg19::chr6:153304166..153304194,-p1@FBXO5
Hg19::chr6:49431073..49431135,+p1@CENPQ
Hg19::chr6:52149475..52149587,-p1@MCM3
Hg19::chr6:80714332..80714411,+p1@TTK
Hg19::chr6:97731019..97731118,-p1@MMS22L
Hg19::chr7:152373182..152373198,-p2@XRCC2
Hg19::chr7:152373216..152373260,-p1@XRCC2
Hg19::chr7:158497431..158497529,-p1@NCAPG2
Hg19::chr8:25316707..25316729,+p2@CDCA2
Hg19::chr8:25316737..25316787,+p1@CDCA2
Hg19::chr8:27632034..27632045,+p3@ESCO2
Hg19::chr8:27632047..27632080,+p1@ESCO2
Hg19::chr8:27632083..27632099,+p2@ESCO2
Hg19::chr8:95487272..95487330,-p1@RAD54B
Hg19::chr8:95487331..95487359,-p3@RAD54B
Hg19::chr9:106856558..106856634,+p1@SMC2
Hg19::chr9:36572851..36572932,+p1@MELK
Hg19::chrX:100353153..100353207,+p1@CENPI
Hg19::chrX:14891150..14891201,-p1@FANCB
Hg19::chrX:69509927..69509970,+p1@KIF4A
Hg19::chrX:71458802..71458891,-p1@ERCC6L


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C109&oldid=1701593"